Pharmacological Activation of Brown Adipose Tissue Metabolism

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 5, 2016

Primary Completion Date

May 24, 2018

Study Completion Date

July 5, 2018

Conditions
Type 2 Diabetes
Interventions
DRUG

Mirbetriq (Mirabegron)

50mg of Mirabegron will be administered orally at time 0 in protocol A.

OTHER

cold exposure

Acute cold exposure protocol using a water-conditioned cooling suit will be applied from time 120 to 300 min in protocol B

RADIATION

injection of 18FDG

I.v. injection of 18-fluorodeoxyglucose (18FDG) will be performed at time 270 min, followed by 30 min dynamic PET/CT scanning

RADIATION

injection of 11C-acetate

i.v. injection of 11C-acetate will be performed, followed by 20 min dynamic PET/CT scanning

RADIATION

[3-3H]-glucose

i.v. administration of 1.5 uCi/min of \[3-3H\]-glucose

OTHER

[U-13C]-palmitate

i.v. administration of 0.08 umol/kg/min of \[U-13C\]-palmitate

OTHER

2H-Glycerol

i.v. administration of 0.05 µmol/kg/min of 2H-glycerol

Trial Locations (1)

J1H 5N4

centre de recherche du CHUS, Sherbrooke

All Listed Sponsors
lead

Université de Sherbrooke

OTHER

NCT02811289 - Pharmacological Activation of Brown Adipose Tissue Metabolism | Biotech Hunter | Biotech Hunter